US Stock MarketDetailed Quotes

TCRR TCR2 Therapeutics

Watchlist

1.480
0.0000.00%

Close Jun 2 09:30 ET

58.11MMarket Cap-352P/E (TTM)

TCR2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-28.51%-40.01M

-24.33%-101.46M

-7.20%-24.96M

-33.32%-25.84M

-30.08%-19.53M

-30.12%-31.13M

-43.82%-81.6M

-72.46%-23.28M

-79.14%-19.38M

6.22%-15.02M

Net income from continuing operations

-38.72%-40.4M

-52.12%-151.82M

-118.12%-60.51M

-16.58%-30.59M

-29.98%-31.6M

-35.38%-29.12M

-48.69%-99.81M

-50.34%-27.74M

-55.09%-26.24M

-49.66%-24.31M

Depreciation and amortization

-12.89%615K

7.75%3.05M

-12.34%746K

15.14%890K

2.03%704K

37.62%706K

77.58%2.83M

78.03%851K

75.28%773K

88.01%690K

Deferred tax

--0

-395.96%-293K

--0

-1,262.96%-314K

-41.67%21K

-24.43%99K

-113.33%-6K

-51.16%42K

--27K

Change In working capital

33.91%-3.37M

1,321.94%9.58M

321.51%5.09M

-45.91%1.44M

59.79%8.16M

18.29%-5.11M

-189.91%-784K

-202.04%-2.3M

-28.12%2.65M

359.42%5.11M

-Change in prepaid assets

62.95%-1.63M

322.64%5.56M

219.71%2.94M

233.85%1.5M

210.93%5.52M

-94.26%-4.4M

-126.70%-2.5M

-417.18%-2.46M

-72.57%449K

192.30%1.78M

-Change in payables and accrued expense

162.13%671K

-67.47%1.34M

907.59%1.91M

-43.69%901K

-113.33%-392K

-517.14%-1.08M

109.22%4.13M

-116.05%-237K

-22.10%1.6M

6,491.30%2.94M

-Change in other working capital

-744.00%-2.42M

210.93%2.68M

-40.51%235K

-259.77%-965K

672.26%3.04M

109.85%375K

---2.42M

--395K

--604K

--393K

Cash from discontinued investing activities

Operating cash flow

-28.51%-40.01M

-24.33%-101.46M

-7.20%-24.96M

-33.32%-25.84M

-30.08%-19.53M

-30.12%-31.13M

-43.82%-81.6M

-72.46%-23.28M

-79.14%-19.38M

6.22%-15.02M

Investing cash flow

Cash flow from continuing investing activities

118.48%21.69M

-212.80%-88.49M

121.78%3.66M

8.57%35.56M

-122.76%-10.33M

-787.82%-117.37M

260.31%78.45M

-388.42%-16.78M

145.82%32.76M

31.30%45.41M

Net PPE purchase and sale

120.15%385K

-36.26%-15.12M

63.82%-2.44M

-120.85%-4.79M

-763.20%-5.98M

-28.17%-1.91M

-54.91%-11.1M

-45.36%-6.75M

-67.54%-2.17M

4.41%-693K

Net intangibles purchase and sale

--0

5.98%-330K

--0

80.56%-35K

-78.91%-229K

---66K

---351K

---43K

---180K

---128K

Net investment purchase and sale

118.46%21.3M

-181.24%-73.03M

161.01%6.1M

15.04%40.39M

-108.92%-4.12M

-721.90%-115.39M

315.21%89.9M

-195.54%-9.99M

150.00%35.1M

30.93%46.23M

Cash from discontinued investing activities

Investing cash flow

118.48%21.69M

-212.80%-88.49M

121.78%3.66M

8.57%35.56M

-122.76%-10.33M

-787.82%-117.37M

260.31%78.45M

-388.42%-16.78M

145.82%32.76M

31.30%45.41M

Financing cash flow

Cash flow from continuing financing activities

-59.32%24K

-99.91%125K

-68.70%41K

-79.01%72K

-138.52%-47K

-99.96%59K

-1.90%132.14M

-66.15%131K

-99.74%343K

320.69%122K

Net common stock issuance

----

--0

----

-1.68%131.33M

--0

Proceeds from stock option exercised by employees

-70.43%34K

-78.96%256K

--0

-73.90%113K

-86.27%28K

-69.41%115K

2.35%1.22M

-54.36%204K

0.23%433K

63.20%204K

Net other financing activities

82.14%-10K

67.97%-131K

156.16%41K

54.44%-41K

8.54%-75K

65.85%-56K

-570.49%-409K

---73K

---90K

14.58%-82K

Cash from discontinued financing activities

Financing cash flow

-59.32%24K

-99.91%125K

-68.70%41K

-79.01%72K

-138.52%-47K

-99.96%59K

-1.90%132.14M

-66.15%131K

-99.74%343K

320.69%122K

Net cash flow

Beginning cash position

-84.85%33.9M

136.15%223.72M

-79.08%55.16M

-81.85%45.36M

-65.69%75.28M

136.15%223.72M

44.17%94.74M

158.40%263.65M

398.75%249.93M

596.34%219.42M

Current changes in cash

87.67%-18.3M

-247.17%-189.82M

46.76%-21.26M

-28.60%9.8M

-198.02%-29.91M

-219.06%-148.45M

344.38%128.98M

-447.54%-39.93M

-73.58%13.72M

64.05%30.52M

End cash Position

-79.28%15.6M

-84.85%33.9M

-79.08%55.16M

-81.85%45.36M

-65.69%75.28M

136.15%223.72M

158.40%263.65M

398.75%249.93M

Free cash flow

-21.31%-40.17M

-25.64%-116.91M

8.88%-27.4M

-41.11%-30.66M

-62.55%-25.74M

-30.27%-33.11M

-45.61%-93.05M

-65.76%-30.07M

-79.39%-21.73M

5.38%-15.84M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-28.51%-40.01M	-24.33%-101.46M	-7.20%-24.96M	-33.32%-25.84M	-30.08%-19.53M	-30.12%-31.13M	-43.82%-81.6M	-72.46%-23.28M	-79.14%-19.38M	6.22%-15.02M
Net income from continuing operations	-38.72%-40.4M	-52.12%-151.82M	-118.12%-60.51M	-16.58%-30.59M	-29.98%-31.6M	-35.38%-29.12M	-48.69%-99.81M	-50.34%-27.74M	-55.09%-26.24M	-49.66%-24.31M
Depreciation and amortization	-12.89%615K	7.75%3.05M	-12.34%746K	15.14%890K	2.03%704K	37.62%706K	77.58%2.83M	78.03%851K	75.28%773K	88.01%690K
Deferred tax	--0	-395.96%-293K	--0	--0	-1,262.96%-314K	-41.67%21K	-24.43%99K	-113.33%-6K	-51.16%42K	--27K
Change In working capital	33.91%-3.37M	1,321.94%9.58M	321.51%5.09M	-45.91%1.44M	59.79%8.16M	18.29%-5.11M	-189.91%-784K	-202.04%-2.3M	-28.12%2.65M	359.42%5.11M
-Change in prepaid assets	62.95%-1.63M	322.64%5.56M	219.71%2.94M	233.85%1.5M	210.93%5.52M	-94.26%-4.4M	-126.70%-2.5M	-417.18%-2.46M	-72.57%449K	192.30%1.78M
-Change in payables and accrued expense	162.13%671K	-67.47%1.34M	907.59%1.91M	-43.69%901K	-113.33%-392K	-517.14%-1.08M	109.22%4.13M	-116.05%-237K	-22.10%1.6M	6,491.30%2.94M
-Change in other working capital	-744.00%-2.42M	210.93%2.68M	-40.51%235K	-259.77%-965K	672.26%3.04M	109.85%375K	---2.42M	--395K	--604K	--393K
Cash from discontinued investing activities
Operating cash flow	-28.51%-40.01M	-24.33%-101.46M	-7.20%-24.96M	-33.32%-25.84M	-30.08%-19.53M	-30.12%-31.13M	-43.82%-81.6M	-72.46%-23.28M	-79.14%-19.38M	6.22%-15.02M
Investing cash flow
Cash flow from continuing investing activities	118.48%21.69M	-212.80%-88.49M	121.78%3.66M	8.57%35.56M	-122.76%-10.33M	-787.82%-117.37M	260.31%78.45M	-388.42%-16.78M	145.82%32.76M	31.30%45.41M
Net PPE purchase and sale	120.15%385K	-36.26%-15.12M	63.82%-2.44M	-120.85%-4.79M	-763.20%-5.98M	-28.17%-1.91M	-54.91%-11.1M	-45.36%-6.75M	-67.54%-2.17M	4.41%-693K
Net intangibles purchase and sale	--0	5.98%-330K	--0	80.56%-35K	-78.91%-229K	---66K	---351K	---43K	---180K	---128K
Net investment purchase and sale	118.46%21.3M	-181.24%-73.03M	161.01%6.1M	15.04%40.39M	-108.92%-4.12M	-721.90%-115.39M	315.21%89.9M	-195.54%-9.99M	150.00%35.1M	30.93%46.23M
Cash from discontinued investing activities
Investing cash flow	118.48%21.69M	-212.80%-88.49M	121.78%3.66M	8.57%35.56M	-122.76%-10.33M	-787.82%-117.37M	260.31%78.45M	-388.42%-16.78M	145.82%32.76M	31.30%45.41M
Financing cash flow
Cash flow from continuing financing activities	-59.32%24K	-99.91%125K	-68.70%41K	-79.01%72K	-138.52%-47K	-99.96%59K	-1.90%132.14M	-66.15%131K	-99.74%343K	320.69%122K
Net common stock issuance	----	--0	--0	--0	----	----	-1.68%131.33M	--0	--0	--0
Proceeds from stock option exercised by employees	-70.43%34K	-78.96%256K	--0	-73.90%113K	-86.27%28K	-69.41%115K	2.35%1.22M	-54.36%204K	0.23%433K	63.20%204K
Net other financing activities	82.14%-10K	67.97%-131K	156.16%41K	54.44%-41K	8.54%-75K	65.85%-56K	-570.49%-409K	---73K	---90K	14.58%-82K
Cash from discontinued financing activities
Financing cash flow	-59.32%24K	-99.91%125K	-68.70%41K	-79.01%72K	-138.52%-47K	-99.96%59K	-1.90%132.14M	-66.15%131K	-99.74%343K	320.69%122K
Net cash flow
Beginning cash position	-84.85%33.9M	136.15%223.72M	-79.08%55.16M	-81.85%45.36M	-65.69%75.28M	136.15%223.72M	44.17%94.74M	158.40%263.65M	398.75%249.93M	596.34%219.42M
Current changes in cash	87.67%-18.3M	-247.17%-189.82M	46.76%-21.26M	-28.60%9.8M	-198.02%-29.91M	-219.06%-148.45M	344.38%128.98M	-447.54%-39.93M	-73.58%13.72M	64.05%30.52M
End cash Position	-79.28%15.6M	-84.85%33.9M	-84.85%33.9M	-79.08%55.16M	-81.85%45.36M	-65.69%75.28M	136.15%223.72M	136.15%223.72M	158.40%263.65M	398.75%249.93M
Free cash flow	-21.31%-40.17M	-25.64%-116.91M	8.88%-27.4M	-41.11%-30.66M	-62.55%-25.74M	-30.27%-33.11M	-45.61%-93.05M	-65.76%-30.07M	-79.39%-21.73M	5.38%-15.84M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data